Home/Filings/4/0000899243-20-032411
4//SEC Filing

BAY CITY CAPITAL LLC 4

Accession 0000899243-20-032411

CIK 0001157601other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 9:36 PM ET

Size

11.6 KB

Accession

0000899243-20-032411

Insider Transaction Report

Form 4
Period: 2020-12-01
BAY CITY CAPITAL LLC
Director10% Owner
Transactions
  • Other

    Common Stock

    2020-12-0143,5372,310,521 total(indirect: See Footnotes)
Transactions
  • Other

    Common Stock

    2020-12-0143,5372,310,521 total(indirect: See Footnotes)
Transactions
  • Other

    Common Stock

    2020-12-0143,5372,310,521 total(indirect: See Footnotes)
Transactions
  • Other

    Common Stock

    2020-12-0143,5372,310,521 total(indirect: See Footnotes)
Footnotes (2)
  • [F1]Represents a transfer, without the payment of any consideration, to an affiliate.
  • [F2]Includes 2,260,791 shares of common stock held by Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and 49,730 shares of common stock held by Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV"). Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Fund IV and Co-Investment IV are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001288452

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:36 PM ET
Size
11.6 KB